← all drugs
Dopamine Hydrochloride Injection
in shortage · Cardiovascular · Snapshot: 2026-10-09
Day 3,259
of this shortage, counting from the FDA's first posting on 11/06/2017
- Manufacturers listed
- Baxter Healthcare, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
- Reported reason(s)
- Demand increase for the drug; Other
- Machine-readable
- JSON for this drug
Presentations (11)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Baxter Healthcare | Available | 10/02/2026 |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Baxter Healthcare | Available | 10/02/2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Baxter Healthcare | Available | 10/02/2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Baxter Healthcare | Available | 10/02/2026 |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-15 — Dopamine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-08-28 — Dopamine Hydrochloride Injection: availability wording revised for 2 presentation(s)
- 2026-08-27 — Dopamine Hydrochloride Injection: availability wording revised for 1 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.